Avacta Group (AVCT)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

48.50p
   
  • Change Today:
      0.50p
  • 52 Week High: 159.60
  • 52 Week Low: 45.50
  • Currency: UK Pounds
  • Shares Issued: 350.51m
  • Volume: 2,975,500
  • Market Cap: £170.00m
  • RiskGrade: 461

ShareCast News

Avacta buying Launch Diagnostics for initial £24m 18-Oct-2022 ShareCast
Avacta losses narrow as it progresses clinical p... 29-Sep-2022 ShareCast
Avacta's soft tissue sarcoma treatment gets FDA ... 05-Sep-2022 ShareCast
Avacta joint venture completes fresh funding round 21-Jul-2022 ShareCast
Avacta triggers milestone in Daewoong joint vent... 13-Apr-2022 ShareCast
Avacta joint venture enters new immune model col... 08-Apr-2022 ShareCast
Avacta offloads animal health unit in £2.3m deal 16-Mar-2022 ShareCast
Avacta moves to next dose in first-in-human chem... 03-Feb-2022 ShareCast
Avacta Group selects second pro-drug candidate 18-Jan-2022 ShareCast
Shares plummet as Avacta pauses sale of lateral ... 10-Jan-2022 ShareCast
Avacta antigen lateral flow test shown to detect... 15-Dec-2021 ShareCast
FDA gives Avacta the go-ahead for US chemotherap... 29-Nov-2021 ShareCast
Avacta suspends UK Covid test sales ahead of new... 02-Nov-2021 ShareCast
Avacta losses widen as development spend increases 30-Sep-2021 ShareCast
Avacta gets undisclosed milestone payment from L... 29-Sep-2021 ShareCast
First patient dosed in Avacta's 'AVA6000' trial 11-Aug-2021 ShareCast
Avacta gets ISO certification for Affirmer manuf... 14-Jul-2021 ShareCast
Avacta rapid Covid-19 test detects Delta variant... 29-Jun-2021 ShareCast
Avacta enters non-exclusive distribution deal fo... 21-Jun-2021 ShareCast
Avacta to sell rapid Covid-19 test in EU followi... 11-Jun-2021 ShareCast
Avacta gets MHRA registration for rapid Covid-19... 07-Jun-2021 ShareCast
Avacta confident despite filing delay for Covid-... 01-Jun-2021 ShareCast
Avacta still waiting on MHRA approval for Covid-... 28-May-2021 ShareCast
Avacta reports positive data for Covid-19 test p... 20-Apr-2021 ShareCast
Avacta signs global distribution deal with Abcam 06-Apr-2021 ShareCast
Avacta enters licence deal with Werfen subsidiar... 09-Mar-2021 ShareCast
Avacta confirms efficacy of test on variant Covi... 08-Mar-2021 ShareCast
Avacta clarifies reports on potential use of its... 22-Feb-2021 ShareCast
Avacta gets approval for first-in-human study of... 18-Feb-2021 ShareCast
Avacta upbeat on initial data for Covid-19 rapid... 16-Feb-2021 ShareCast
Avacta enters commercial partnership with Mologic 08-Feb-2021 ShareCast
Avacta joint venture with Daewoong raises $7.3m ... 01-Feb-2021 ShareCast
Avacta to collaborate with Bruker to assess Covi... 28-Jan-2021 ShareCast
Avacta enters licence agreement with Point Bioph... 07-Jan-2021 ShareCast
Avacta submits clinical trial application for 'A... 23-Dec-2020 ShareCast
Avacta enters 'Affimer' licensing deal with Astr... 21-Dec-2020 ShareCast
Avacta reports 'significant progress' on Covid-1... 23-Nov-2020 ShareCast
Avacta launching Covid-19 laboratory test 07-Sep-2020 ShareCast
Avacta signs Covid-19 test manufacturing deal wi... 02-Sep-2020 ShareCast
Avacta expands collaboration deal with LG Chem 18-Aug-2020 ShareCast
Avacta ropes in Neil Bell as chief development o... 11-Aug-2020 ShareCast
Avacta to collaborate with Liverpool School of T... 07-Aug-2020 ShareCast
Avacta appoints BBI Solutions as manufacturing p... 06-Aug-2020 ShareCast
Avacta expands partnership with Daewoong to Covi... 29-Jul-2020 ShareCast
Avacta's Covid test collaboration with Adeptrix ... 22-Jul-2020 ShareCast
Avacta signs Covid sewage test deal with Integumen 13-Jul-2020 ShareCast
Avacta upbeat on evaluation of Covid-19 test str... 24-Jun-2020 ShareCast
Avacta reports promising findings on potential C... 18-Jun-2020 ShareCast
Avacta's Covid-19 test reaches prototype stage 09-Jun-2020 ShareCast
Avacta raising £45m to fund diagnostics and ther... 04-Jun-2020 ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Avacta Group Market Data

Currency UK Pounds
Share Price 48.50p
Change Today 0.50p
% Change 1.04 %
52 Week High 159.60
52 Week Low 45.50
Volume 2,975,500
Shares Issued 350.51m
Market Cap £170.00m
RiskGrade 461

Avacta Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.01% below the market average35.01% below the market average35.01% below the market average35.01% below the market average35.01% below the market average
50.94% below the sector average50.94% below the sector average50.94% below the sector average50.94% below the sector average50.94% below the sector average
Price Trend
86.7% below the market average86.7% below the market average86.7% below the market average86.7% below the market average86.7% below the market average
50.88% below the sector average50.88% below the sector average50.88% below the sector average50.88% below the sector average50.88% below the sector average
Income Not Available
Growth
58.30% above the market average58.30% above the market average58.30% above the market average58.30% above the market average58.30% above the market average
83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average

What The Brokers Say

Strong Buy 0
Buy 2
Neutral 0
Sell 1
Strong Sell 0
Total 3
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Avacta Group Dividends

No dividends found

Trades for 19-Apr-2024

Time Volume / Share Price
16:35 250 @ 48.50p
16:35 187 @ 48.50p
16:35 7 @ 48.50p
16:35 56 @ 48.50p
16:29 3,000 @ 47.40p

Avacta Group Key Personnel

CEO Alastair Smith
CFO Tony Peter Gardiner

Top of Page